Spectrofluorometric determination of some β-blockers in tablets and human plasma using 9,10-dimethoxyanthracene-2-sodium sulfonate

Pharmazie

Volumn 60, Issue 4, 2005, Pages 265-268

  Abdine, H ^a   Sultan, M A ^a   Hefnawy, M M ^a   Belal, F ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

9,10 DIMETHOXYANTHRACENE 2 SODIUM SULFONATE; ANTHRACENE DERIVATIVE; AROTINOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLOROFORM; HYPOTEN; LABETALOL; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUORESCENCE; HUMAN; IN VITRO STUDY; PLASMA; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; ROOM TEMPERATURE; SPECTROFLUOROMETRY; STOICHIOMETRY; TABLET;

ADRENERGIC BETA-ANTAGONISTS; ANTHRACENES; ATENOLOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INDICATORS AND REAGENTS; LABETALOL; PROPANOLAMINES; REFERENCE STANDARDS; SPECTROMETRY, FLUORESCENCE; TABLETS;

EID: 17644370658     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aboul-Enein YY, Hefnawy MM (2003) Enantioselective determination of arotinolol in human plasma by HPLC using teicoplanin chiral stationary phase. Biomed Chromatogr 17: 453-457.
2. Amin AS, Ragab GH, Saleh H (2002) Colorimetric determination of β-blockers in pharmaceutical formulations. J Pharm Biomed Anal 30: 1347-1353.
3. Arranz A, Dolara I, deFernandez S, Betono JM, Moreda AC, Arranz JF (1999) Electroanalytical study and square wave voltammetric techniques for the determination of β-blocker timolol at the mercury electrode. Anal Chim Acta 389: 225-232.
4. Badaloni E, D'Acquarica I, Gasparrini F, Lalli S, Misiti D, Passucconi F, Sirtori R (2003) Enantioselective liquid chromatographic-electrospray mass spectrometric assay of β-adrenergic blockers; application to a pharmacokinetic study of sotaolol in human plasma. J Chromatogr B 796: 45-54.
5. Belal F, Al-Shaboury S, Al-Tamrah AS (2002) Spectrophotometric determination of labetaolol in pharmaceutical preparations and spiked human urine. Farmaco 58: 293-299.
6. Belal F, Al-Shaboury S, Al-Tamrah AS (2002a) Spectrofluorometric determination of labetalol in pharmaceutical preparations and spiked urine through the formation of coumarins derivative. J Pharm Biomed Anal 30: 1191-1196.
7. Black SB, Stenhouse AM, Hansson RC (1996) Solid-phase extraction and derivatization methods for β-blockers in human post mortem whole blood, urine and equine urine. J Chromatogr B 685: 67-80.
8. Ceniceros C, Maguregui ML, Jimenez RM, Alonso RM (1998) Quantitative determination of the β-blocker labetaolol in pharmaceutical liquid chromatography with amperometric detection. J Chromatogr B 705: 97-103.
9. Fernandez P, Alder AC, Suter MJF, Goger W. (1996) Determination of the quaternary ammonium surfactants ditallowdimethylammonium Anal Chem 68: 921-929.
10. Haas M, Moolenaar F, Kluppel ACA, Dijkstra D, Meiyer D KF, de Zeeuw, D. (1997) Determination of dopaminergic prodrugs by high-performance liquid chromatography followed by post-column ion-pair extraction J Chromatogr B 693: 484-488.
11. Hassan SM, Abou-Sekkina MM, El-Ries MA, Wassel AA (2003) Polymeric matrix membrane sensors for sensitive potentiometric determination of some β-blockers in pharmaceutical preparations. J Pharm Biomed Anal 32: 175-180.
12. Hefnawy MM (2003) Micellar electrokinetic capillary chromatography determination of +S and -R arotinolol in serum using UV detection and solid phase extraction. Chirality 14: 67-71.
13. Hesham S (2002) Spectrophotometric determination of β-adrenergic blocking agents in pharmaceutical formulations. J Pharm Biomed Anal 29: 527-538.
14. Miller JC, Miller JN (1983) In: Statistics for Analytical Chemistry, John Wiley and Sons, New York, p. 83.
15. Murillo-Pulgarin JA, Alanon-Molina A, Fernandez-Lopez P (1998) Simultaneous determination of atenolol, propranolol, dipyridamole and amiloride by means of non-linear variable-angle synchronous fluorescence spectrometry. Anal Chim Acta 370: 9-18.
16. Park YJY, Dai WL, Lee WY (2002) Determination of β-blockers in pharmaceutical preparations and human urine by high performance liquid chromatography with tris (2,2́-bipyridyl)ruthenium(II) electrogenerated chemiluminescence detection. Anal Chim Acta 471: 51-59.
17. Ranta VP, Toropainen E, Talvitie A, Auriola S, Urtti A (2002) Simultaneous determination of eight β-blockers by gradient high-performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro. J Chromatogr B. 772: 81-87.
18. Riley CM, Monnot A, Stobaugh JF, Slavik J (1989) Determination of spirogermanium (2-aza-8-germanspiro[4.5]decane-2-propanamine-8,8-diethyl-N,N- dimethyl chloride) by fluorometric ion-pair extraction. Application to the uniformity content of solutions for intravenous injection. J Pharm Biomed Anal 7: 385-392.
19. Rose J (1964) In: Advanced Physicochemical Experiments, Pitman, London p. 67.
20. Siren H, Saayinen M, Hainan S, Lukkari P, Riekkola ML (1993) Screening of β-blockers in human serum by ion-pair chromatography and their identification as methyl or acetyl derivatives by gas chromatography-mass- spectrometry. J Chromatogr 632: 215-227.
21. The British Pharmacopoeia, Her Majesty's Stationary Office, London (1998) pp. 884, 1904.
22. The United States Pharmacopoeia, USA 23 NF18 US Pharmaceutical Convention, Rockville, MD (1995) p. 1327.